Company Active LTD

Company profile

Mina Alpha Limited

MiNA Therapeutics | RNA Activation MiNA Therapeutics | RNA Activation

Mina Alpha Limited is a UK company with status active founded in 2012.

CRN
08186196
Founded
2012
Age
13

Overview

Legal name
MINA ALPHA LIMITED
Region
Unknown
Registered address
TRANSLATION & INNOVATION HUB
84 WOOD LANE
LONDON
UNITED KINGDOM
W12 0BZ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Mina Alpha Limited
CRN 08186196
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

04 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

20 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

16 Aug
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzMjQ3OTgyNmFkaXF6a2N4

Published 16 Aug 2024 10:14

16 Aug
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzMjQ3OTgyNWFkaXF6a2N4

Published 16 Aug 2024 10:14

21 Aug
2012

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2017
Funded years
2017
Age at first award
5 years

Projects

2017 Collaborative R&D Lead participant

Development of liver targeted gene activation for liver disease

1 Sep 2017 to 31 May 2019

Awarded
£217,844
Total cost £311,206

The project is developing an innovative drug for advanced liver disease including non-alcoholic steatohepatitis (NASH) where there are limited existing treatment options. The drug is designed to be administered subcutaneously, selectively target to the liver and increase the expression of a protein in the liver which is down-regulated in disease. Increasi...

Product types

Collaborative R&D